Score Breakdown
Offering Ability
40
Cash Runway
85
Float Risk
55
Warrant Exposure
40
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 60%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.23 below $1 exchange minimum
• Only 4 months cash — financial pressure
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 261% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 35%
• Low cash runway: 4 months remaining
Market Data
Market Cap$3.45M
Shares Outstanding71.95M
Float38.31M
Cash$30.66M
Debt$16.66M
Short InterestN/A
Institutional Holdings
QoQ: ↓ 44.4% shares (2026Q1 vs prior)
13 institutional holders · 4.82M shares
#1
MORGAN STANLEY
1.41M shares
#2
Ikarian Capital, LLC
1.39M shares
#3
BOOTHBAY FUND MANAGEMENT, LLC
451.9K shares
+ 10 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2025-09-30
xbrl
XBRL CONVERTIBLE
2021-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual IOBT Dilution Snapshot
IO Biotech, Inc. (IOBT) has a DilutionScore of 62/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for IOBT: xbrl on 2025-09-30; xbrl on 2021-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: